Related Experiment Video
Updated: Jun 16, 2026

Targeted Knockdown of Genes in the Choroid Plexus
Published on: June 16, 2023
Contributions of selective knockout studies to understanding cholinesterase disposition and function
Shelley Camp1, Limin Zhang, Eric Krejci
1Department Pharmacology, Skaggs School of Pharmacy & Pharmaceutical Sciences 0657, University of California-San Diego, La Jolla, CA 92093-0657, USA. scamp@ucsd.edu
Complete knockout of acetylcholinesterase (AChE) in mice revealed a viable but functionally impaired animal. Targeted gene deletions elucidated AChE
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- The acetylcholinesterase (AChE) gene in mammals is subject to alternative splicing, leading to diverse protein functions.
- Previous studies in Drosophila suggested complete gene deletion would be lethal, but mouse models show a different outcome.
Purpose of the Study:
- To investigate the functional roles of alternatively spliced exons in AChE tissue distribution and activity.
- To understand the impact of specific gene deletions on AChE function in vivo.
Main Methods:
- Generation of transgenic mouse strains with targeted deletions of AChE exons 5, 6, or both.
- Creation of knockout strains for AChE anchoring proteins PRiMA and ColQ.
- Development of a knockout mouse with a deletion in an upstream intronic regulatory region controlling AChE expression.
Main Results:
- Deletion of exon 6 significantly reduced brain (93%) and muscle (72%) AChE levels.
- Deletion of exon 5 eliminated AChE from red blood cells and platelet surfaces.
- Intronic regulatory region deletion primarily affected muscle and platelet surface AChE.
Conclusions:
- Alternative splicing of the AChE gene is crucial for its tissue-specific localization and function in mammals.
- Targeted gene modifications in mice provide critical insights into AChE's in vivo roles, complementing in vitro studies.
Related Concept Videos
Cholinesterases: Distribution and Function
In-vitro Mutagenesis
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...

